NNVC

Nanoviricides Inc

$1.24

-0.14 (-10.14%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$7.00
(+464.52%)
Strong Buy: 0
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
NanoViricides Inc. (NNVC) is an innovative nanobiopharmaceutical firm headquartered in Shelton, Connecticut, dedicated to the research and development of cutting-edge antiviral therapies. Leveraging its proprietary nanomedicine platform, the company creates targeted treatments that address various viral infections and significant unmet medical needs within the healthcare sector. With a robust clinical and preclinical pipeline, NanoViricides is well-positioned for substantial growth in the evolving landscape of antiviral solutions and continues to make strides in bringing its advanced therapies to market.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
1 CONTROLS DRIVE, SHELTON, CT, UNITED STATES, 06484
Fiscal year end:
June
Market capitalization:
$24.1 Million
EBITDA:
-$8.85 Million
PERatio:
0.0
EPS:
-0.63
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.136

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-93%
How much will you get:
$69
Prices dates:
30-10-2015: $24.20 and 31-10-2025: $1.66